Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Colchicine for the Prevention of Recurrence in Cerebral Amyloid Angiopathy RElated IntraCerebral Hemorrhage (CARE-ICH)

NCT07026994 is registered in ClinicalTrials.gov with Huashan Hospital as lead sponsor.

NCT NCT07026994
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07026994 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Colchicine for the Prevention of Recurrence in Cerebral Amyloid Angiopathy RElated IntraCerebral Hemorrhage (CARE-ICH)
Lead sponsor
Huashan Hospital
Phase
Phase 2
Overall status
Recruiting
Start date
June 18, 2025
Completion date
December 31, 2027
Enrollment
80 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral amyloid angiopathy, intracerebral hemorrhage lobar